These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18847385)

  • 21. Factor analysis of cardiovascular risk clustering in pediatric metabolic syndrome: CASPIAN study.
    Kelishadi R; Ardalan G; Adeli K; Motaghian M; Majdzadeh R; Mahmood-Arabi MS; Delavari A; Riazi MM; Namazi R; Ramezani MA;
    Ann Nutr Metab; 2007; 51(3):208-15. PubMed ID: 17587791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nontraditional cardiovascular risk factors in pediatric metabolic syndrome.
    Retnakaran R; Zinman B; Connelly PW; Harris SB; Hanley AJ
    J Pediatr; 2006 Feb; 148(2):176-82. PubMed ID: 16492425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High prevalence of abdominal obesity increases the risk of the metabolic syndrome in Nigerian type 2 diabetes patients: using the International Diabetes Federation worldwide definition.
    Ezenwaka CE; Okoye O; Esonwune C; Onuoha P; Dioka C; Osuji C; Oguejiofor C; Meludu S
    Metab Syndr Relat Disord; 2014 Jun; 12(5):277-82. PubMed ID: 24601861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of overweight, obesity and metabolic syndrome components in children, adolescents and young adults with type 1 diabetes mellitus.
    Pinhas-Hamiel O; Levek-Motola N; Kaidar K; Boyko V; Tisch E; Mazor-Aronovitch K; Graf-Barel C; Landau Z; Lerner-Geva L; Frumkin Ben-David R
    Diabetes Metab Res Rev; 2015 Jan; 31(1):76-84. PubMed ID: 24827815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Waist circumference as a screening tool for the identification of adolescents with the metabolic syndrome phenotype.
    Bitsori M; Linardakis M; Tabakaki M; Kafatos A
    Int J Pediatr Obes; 2009; 4(4):325-31. PubMed ID: 19922048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of metabolic alterations predictive of cardiovascular disease risk in the Québec population.
    Scarsella C; Alméras N; Mauriège P; Blanchet C; Sauvé L; Dewailly E; Bergeron J; Després JP
    Can J Cardiol; 2003 Jan; 19(1):51-7. PubMed ID: 12571695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma fatty acid composition, estimated desaturase activities, and their relation with the metabolic syndrome in a population at high risk of cardiovascular disease.
    Mayneris-Perxachs J; Guerendiain M; Castellote AI; Estruch R; Covas MI; Fitó M; Salas-Salvadó J; Martínez-González MA; Aros F; Lamuela-Raventós RM; López-Sabater MC;
    Clin Nutr; 2014 Feb; 33(1):90-7. PubMed ID: 23591154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistent high prevalence of cardiovascular risk factors in the urban middle class in India: Jaipur Heart Watch-5.
    Gupta R; Sharma KK; Gupta A; Agrawal A; Mohan I; Gupta VP; Khedar RS; Guptha S
    J Assoc Physicians India; 2012 Mar; 60():11-6. PubMed ID: 22799108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucose, insulin, diabetes and mechanisms of arterial dysfunction.
    Cameron JD; Cruickshank JK
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):677-82. PubMed ID: 17581229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid abnormalities are prevalent in youth with type 1 and type 2 diabetes: the SEARCH for Diabetes in Youth Study.
    Kershnar AK; Daniels SR; Imperatore G; Palla SL; Petitti DB; Pettitt DJ; Marcovina S; Dolan LM; Hamman RF; Liese AD; Pihoker C; Rodriguez BL
    J Pediatr; 2006 Sep; 149(3):314-9. PubMed ID: 16939739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease.
    Meigs JB; Wilson PW; Fox CS; Vasan RS; Nathan DM; Sullivan LM; D'Agostino RB
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2906-12. PubMed ID: 16735483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative androgen deficiency in relation to obesity and metabolic status in older men.
    Chen RY; Wittert GA; Andrews GR
    Diabetes Obes Metab; 2006 Jul; 8(4):429-35. PubMed ID: 16776750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet mean volume, distribution width, and count in type 2 diabetes, impaired fasting glucose, and metabolic syndrome: a meta-analysis.
    Zaccardi F; Rocca B; Pitocco D; Tanese L; Rizzi A; Ghirlanda G
    Diabetes Metab Res Rev; 2015 May; 31(4):402-10. PubMed ID: 25421610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered plasma adipokines and markers of oxidative stress suggest increased risk of cardiovascular disease in First Nation youth with obesity or type 2 diabetes mellitus.
    Stringer DM; Sellers EA; Burr LL; Taylor CG
    Pediatr Diabetes; 2009 Jun; 10(4):269-77. PubMed ID: 19175895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic changes in type 2 diabetes are reflected in peripheral blood cells, revealing aberrant cytotoxicity, a viral signature, and hypoxia inducible factor activity.
    van der Pouw Kraan TC; Chen WJ; Bunck MC; van Raalte DH; van der Zijl NJ; van Genugten RE; van Bloemendaal L; Baggen JM; Serné EH; Diamant M; Horrevoets AJ
    BMC Med Genomics; 2015 May; 8():20. PubMed ID: 25956355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type 2 diabetes mellitus: a high-risk condition for cardiovascular disease irrespective of the different degrees of obesity.
    Song SH; Hardisty CA
    QJM; 2008 Nov; 101(11):875-9. PubMed ID: 18776208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietary patterns and markers for the metabolic syndrome in Australian adolescents.
    Ambrosini GL; Huang RC; Mori TA; Hands BP; O'Sullivan TA; de Klerk NH; Beilin LJ; Oddy WH
    Nutr Metab Cardiovasc Dis; 2010 May; 20(4):274-83. PubMed ID: 19748245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoproteins in diabetes dyslipidaemia in South Asians with young adult-onset diabetes: distribution, associations and patterns.
    Katulanda GW; Katulanda P; Adler AI; Peiris SR; Draisey I; Wijeratne S; Sheriff R; Matthews DR; Shine B
    Ann Clin Biochem; 2010 Jan; 47(Pt 1):29-34. PubMed ID: 19952033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of the DiabetIMSS program on cardiovascular risk, blood pressure and HDL cholesterol in patients with metabolic syndrome].
    Mendoza-Romo MA; Montes-Acuña JF; Zavala-Cruz GG; Nieva-de Jesús RN; Ramírez-Arreola MC; Andrade-Rodríguez HJ
    Rev Med Inst Mex Seguro Soc; 2017; 55(1):32-39. PubMed ID: 28092245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type 1 and type 2 diabetes mellitus and incidence of seven cardiovascular diseases.
    Larsson SC; Wallin A; Håkansson N; Stackelberg O; Bäck M; Wolk A
    Int J Cardiol; 2018 Jul; 262():66-70. PubMed ID: 29605469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.